A/Prof Steven Rockman
Honorary (Principal Fellow)
Department of Microbiology and Immunology
114 Scholarly works
4 Projects
HIGHLIGHTS
2026
Journal article
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
DOI: 10.1038/s41541-025-01355-y2026
Journal article
IFN-gene signatures in B cells following influenza A and B virus infection and influenza vaccination
DOI: 10.1038/s44321-026-00395-82026
Journal article
Historic 1994 influenza vaccine cohorts define breadth of antibody and B cell responses toward future influenza A and B viruses
DOI: 10.1126/scitranslmed.aea86212025
Journal article
Understanding the Implications of Delaying Seasonal Influenza Vaccine Recommendations: An Industry Perspective
DOI: 10.3390/vaccines130908912025
Journal article
The impact of egg adaptation and immune imprinting on influenza vaccine effectiveness
DOI: 10.1016/j.vaccine.2025.1273932021
Research Grant
Accelerated Phase I Trial of Targeted and Tunable SARS-Cov-2 Spike Protein Receptor Binding Domain Recombinant Protein and mRNA Vaccines
2020
Research Grant
A Safe, Effective, and Rapidly Tuneable SARS-CoV-2 Vaccine
RECENT SCHOLARLY WORKS
2025
Journal article
Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale
DOI: 10.1002/bit.289372025
Journal article
Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines
DOI: 10.1172/jci.insight.1870752025
Journal article
Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccines
DOI: 10.3389/fimmu.2025.16961912024
Journal article
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
DOI: 10.1016/j.omtm.2024.1013802024
Journal article
CD8 T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age
DOI: 10.1038/s41467-024-47576-y
RECENT PROJECTS
2021
Research Grant
Accelerated Phase I Trial of Targeted and Tunable SARS-Cov-2 Spike Protein Receptor Binding Domain Recombinant Protein and mRNA Vaccines
2021
Research Grant
Accelerated Phase I Trial of Targeted and Tunable SARS-Cov-2 Spike Protein Receptor Binding Domain Recombinant Protein and mRNA Vaccines